EDWARD GRAVISS to Immunoglobulin G
This is a "connection" page, showing publications EDWARD GRAVISS has written about Immunoglobulin G.
Connection Strength
0.276
-
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG. Am J Pathol. 2021 01; 191(1):90-107.
Score: 0.144
-
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients. Clin Transplant. 2022 05; 36(5):e14600.
Score: 0.039
-
Intravenous immunoglobulin in heart transplant recipients with mild to moderate hypogammaglobulinemia and infection. Clin Transplant. 2022 04; 36(4):e14571.
Score: 0.039
-
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med. 1997 Feb; 45(2):57-68.
Score: 0.028
-
The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis. 1996 Jan; 22(1):165-7.
Score: 0.026